Alzheimer's drug approval spotlights blood tests

Science. 2021 Jul 23;373(6553):373-374. doi: 10.1126/science.373.6553.373.
No abstract available

Publication types

  • News

MeSH terms

  • Alzheimer Disease / blood
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / drug therapy*
  • Amyloid beta-Peptides / blood*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Drug Approval
  • Hematologic Tests*
  • Humans
  • Positron-Emission Tomography
  • tau Proteins / blood*

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized
  • MAPT protein, human
  • tau Proteins
  • aducanumab